Literature DB >> 18510383

From the world literature.

.   

Abstract

Mesh：

Year:  2008        PMID： 18510383     DOI： 10.1007/BF03256284

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


× No keyword cloud information.
  15 in total

1.  The impact of response to the results of diagnostic tests for malaria: cost-benefit analysis.

Authors:  Yoel Lubell; Hugh Reyburn; Hilda Mbakilwa; Rose Mwangi; Semkini Chonya; Christopher J M Whitty; Anne Mills
Journal:  BMJ       Date:  2008-01-16

2.  Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.

Authors:  Donatus U Ekwueme; James G Gardner; Sujha Subramanian; Florence K Tangka; Bela Bapat; Lisa C Richardson
Journal:  Cancer       Date:  2008-02-01       Impact factor: 6.860

3.  Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy.

Authors:  Rowan T Chlebowski; Garnet Anderson; Mary Pettinger; Dorothy Lane; Robert D Langer; Mary Ann Gilligan; Mary Ann Gillian; Brian W Walsh; Chu Chen; Anne McTiernan
Journal:  Arch Intern Med       Date:  2008-02-25

4.  Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD.

Authors:  Nobuyuki Hizawa; Hironi Makita; Yasuyuki Nasuhara; Tomoko Betsuyaku; Yoko Itoh; Katsura Nagai; Masaru Hasegawa; Masaharu Nishimura
Journal:  Chest       Date:  2007-09-21       Impact factor: 9.410

5.  ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy.

Authors:  Stephanie Smith; Dan Su; Irene A Rigault de la Longrais; Peter Schwartz; Manuela Puopolo; Thomas J Rutherford; Gil Mor; Herbert Yu; Dionyssios Katsaros
Journal:  J Clin Oncol       Date:  2007-11-20       Impact factor: 44.544

6.  Effect of gene therapy on visual function in Leber's congenital amaurosis.

Authors:  James W B Bainbridge; Alexander J Smith; Susie S Barker; Scott Robbie; Robert Henderson; Kamaljit Balaggan; Ananth Viswanathan; Graham E Holder; Andrew Stockman; Nick Tyler; Simon Petersen-Jones; Shomi S Bhattacharya; Adrian J Thrasher; Fred W Fitzke; Barrie J Carter; Gary S Rubin; Anthony T Moore; Robin R Ali
Journal:  N Engl J Med       Date:  2008-04-27       Impact factor: 91.245

7.  Effect of genetic polymorphisms on smoking cessation: a trial of bupropion in Korean male smokers.

Authors:  Doug-Hyun Han; Keun-Ho Joe; Chul Na; Young-Sik Lee
Journal:  Psychiatr Genet       Date:  2008-02       Impact factor: 2.458

8.  Intron-2 conversion polymorphism of the aldosterone synthase gene and the antihypertensive response to angiotensin-converting enzyme inhibitors.

Authors:  Huimin Yu; Shuguang Lin; Yuqing Zhang; Guozhang Liu
Journal:  J Hypertens       Date:  2008-02       Impact factor: 4.844

9.  A single-nucleotide polymorphism in the aromatase gene is associated with the efficacy of the aromatase inhibitor letrozole in advanced breast carcinoma.

Authors:  Ramon Colomer; Mariano Monzo; Ignasi Tusquets; Juli Rifa; José M Baena; Agusti Barnadas; Lourdes Calvo; Francisco Carabantes; Carmen Crespo; Montserrat Muñoz; Antonio Llombart; Arrate Plazaola; Rosa Artells; Monstsrrat Gilabert; Belen Lloveras; Emilio Alba
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

10.  Genetic determinants of response to warfarin during initial anticoagulation.

Authors:  Ute I Schwarz; Marylyn D Ritchie; Yuki Bradford; Chun Li; Scott M Dudek; Amy Frye-Anderson; Richard B Kim; Dan M Roden; C Michael Stein
Journal:  N Engl J Med       Date:  2008-03-06       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.